SARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Spike RBD Recombinant Protein | 21-844

SARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Spike RBD Recombinant Protein | 21-844 | Gentaur UK, US & Europe Distribution

Tested Application: N/A

Application: Immunogen

Tpredicted Molecular Weight: 53.21 kDa

Physical State: Lyophilized

Buffer: Supplied as solution form in PBS, pH7.5 or lyophilized from PBS, pH7.5

Storage Condition: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚C for one week . Store at -20 to -80 ˚C for twelve months from the date of receipt.

Alternate Name: S protein RBD, Spike glycoprotein Receptor-binding domain, S glycoprotein RBD, Spike protein RBD, Delta variant spike RBD

Background: N/A

Shipping: N/A

Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.

Source: Mammalian cells

Species: SARS-CoV-2

By Source: Human Cells

By Species: Other

Fusion Tag: C-Fc Tag

Sequence: RBD with mutations at G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H

Bological Activity: N/A

Purity: >90% as determined by SDS-PAGE